Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioClinica and Millennium: The Takeda Oncology Company have entered into a technology agreement to speed up the release of BioClinica’s new Enterprise Demand Aggregator (EDA) product offering, to improve and standardize clinical supply forecasting and management across multiple trials.
Subscribe to our email newsletter
BioClinica said the new EDA will collect planning information from all of Millennium’s Optimizer-simulated protocols in a central repository and provide an enterprise-wide view of the demand over time.
Millennium is using its Optimizer since 2007 for the improving its ability to forecast clinical trial supplies and simulate studies’ requirements.
BioClinica eClinical Solutions president Peter Benton said the pharmaceutical industry relies on technology innovation to drive necessary efficiencies and the partnership demonstrates Millennium’s commitment to innovate while also validating the benefits that BioClinica’s Optimizer technology provides.